138 related articles for article (PubMed ID: 12406874)
1. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen.
Ogawa H; Yin DP; Shen J; Galili U
Blood; 2003 Mar; 101(6):2318-20. PubMed ID: 12406874
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
Ogawa H; Yin DP; Galili U
Gene Ther; 2004 Feb; 11(3):292-301. PubMed ID: 14737089
[TBL] [Abstract][Full Text] [Related]
3. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Mohiuddin MM; Ogawa H; Yin DP; Galili U
Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
[TBL] [Abstract][Full Text] [Related]
4. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.
Ogawa H; Mohiuddin MM; Yin DP; Shen J; Chong AS; Galili U
Transplantation; 2004 Feb; 77(3):366-73. PubMed ID: 14966409
[TBL] [Abstract][Full Text] [Related]
5. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
[TBL] [Abstract][Full Text] [Related]
7. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
Ohdan H; Swenson KG; Kitamura H; Yang YG; Sykes M
Xenotransplantation; 2001 Nov; 8(4):227-38. PubMed ID: 11737848
[TBL] [Abstract][Full Text] [Related]
8. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
[TBL] [Abstract][Full Text] [Related]
9. Elimination of anti-Gal B cells by alpha-Gal ricin1.
Tanemura M; Ogawa H; Yin DP; Chen ZC; DiSesa VJ; Galili U
Transplantation; 2002 Jun; 73(12):1859-68. PubMed ID: 12131678
[TBL] [Abstract][Full Text] [Related]
10. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
Yin D; Ma L; Varghese A; Shen J; Chong AS
J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494
[TBL] [Abstract][Full Text] [Related]
11. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
12. Fetal porcine thymus engraftment, survival and CD4 reconstitution in alphaGal-KO mice is impaired in the presence of high levels of antibodies against alphaGal.
Rodriguez-Barbosa JI; Zhao Y; Houser S; Zhao G; Sykes M
Xenotransplantation; 2003 Jan; 10(1):24-40. PubMed ID: 12535223
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of genetically modified bone marrow cells in sensitized hosts.
Bracy J; Iacomini J
Mol Ther; 2002 Aug; 6(2):252-7. PubMed ID: 12161192
[TBL] [Abstract][Full Text] [Related]
14. Anti-Gal antibodies in humans and 1, 3alpha-galactosyltransferase knock-out mice.
Chiang TR; Fanget L; Gregory R; Tang Y; Ardiet DL; Gao L; Meschter C; Kozikowski AP; Buelow R; Vuist WM
Transplantation; 2000 Jun; 69(12):2593-600. PubMed ID: 10910282
[TBL] [Abstract][Full Text] [Related]
15. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens.
Galili U
Transplantation; 2004 Oct; 78(8):1093-8. PubMed ID: 15502700
[TBL] [Abstract][Full Text] [Related]
16. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
17. Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies.
Galili U
Front Mol Biosci; 2023; 10():1209974. PubMed ID: 37449060
[TBL] [Abstract][Full Text] [Related]
18. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase.
LaTemple DC; Galili U
Xenotransplantation; 1998 Aug; 5(3):191-6. PubMed ID: 9741457
[TBL] [Abstract][Full Text] [Related]
19. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
[TBL] [Abstract][Full Text] [Related]
20. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.
Tanemura M; Yin D; Chong AS; Galili U
J Clin Invest; 2000 Feb; 105(3):301-10. PubMed ID: 10675356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
